Treatment of COPD exacerbations: antibiotics
The debate about the importance of bacterial infection in chronic obstructive pulmonary disease will continue. About half of exacerbations yield positive sputum bacteriology, and the isolation rate can be increased by selection of purulent samples. However, bacteria are also isolated in the stable s...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2005-09-01
|
Series: | European Respiratory Review |
Subjects: | |
Online Access: | http://err.ersjournals.com/cgi/content/full/14/94/32 |
id |
doaj-a0a19b96932744dbbe29692a3972f965 |
---|---|
record_format |
Article |
spelling |
doaj-a0a19b96932744dbbe29692a3972f9652020-11-25T01:29:34ZengEuropean Respiratory SocietyEuropean Respiratory Review0905-91801600-06172005-09-0114943238Treatment of COPD exacerbations: antibioticsR. WilsonThe debate about the importance of bacterial infection in chronic obstructive pulmonary disease will continue. About half of exacerbations yield positive sputum bacteriology, and the isolation rate can be increased by selection of purulent samples. However, bacteria are also isolated in the stable state. The presence of bacteria in sputum alone during an exacerbation does not prove causation. Bacteria have been associated with airway inflammation both in the stable state, when the level of inflammation is related to the size of the bacterial load, and during exacerbations, when resolution of the inflammation is related to bacterial eradication. New evidence has been obtained from epidemiological, immunological and antibiotic studies that supports a role for bacterial infection in causing neutrophilic airway inflammation in chronic obstructive pulmonary disease, and if accepted should lead to new research in the use of antibiotics.http://err.ersjournals.com/cgi/content/full/14/94/32Antibioticschronic obstructive pulmonary diseaseexacerbation |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
R. Wilson |
spellingShingle |
R. Wilson Treatment of COPD exacerbations: antibiotics European Respiratory Review Antibiotics chronic obstructive pulmonary disease exacerbation |
author_facet |
R. Wilson |
author_sort |
R. Wilson |
title |
Treatment of COPD exacerbations: antibiotics |
title_short |
Treatment of COPD exacerbations: antibiotics |
title_full |
Treatment of COPD exacerbations: antibiotics |
title_fullStr |
Treatment of COPD exacerbations: antibiotics |
title_full_unstemmed |
Treatment of COPD exacerbations: antibiotics |
title_sort |
treatment of copd exacerbations: antibiotics |
publisher |
European Respiratory Society |
series |
European Respiratory Review |
issn |
0905-9180 1600-0617 |
publishDate |
2005-09-01 |
description |
The debate about the importance of bacterial infection in chronic obstructive pulmonary disease will continue. About half of exacerbations yield positive sputum bacteriology, and the isolation rate can be increased by selection of purulent samples. However, bacteria are also isolated in the stable state. The presence of bacteria in sputum alone during an exacerbation does not prove causation. Bacteria have been associated with airway inflammation both in the stable state, when the level of inflammation is related to the size of the bacterial load, and during exacerbations, when resolution of the inflammation is related to bacterial eradication. New evidence has been obtained from epidemiological, immunological and antibiotic studies that supports a role for bacterial infection in causing neutrophilic airway inflammation in chronic obstructive pulmonary disease, and if accepted should lead to new research in the use of antibiotics. |
topic |
Antibiotics chronic obstructive pulmonary disease exacerbation |
url |
http://err.ersjournals.com/cgi/content/full/14/94/32 |
work_keys_str_mv |
AT rwilson treatmentofcopdexacerbationsantibiotics |
_version_ |
1725096316146548736 |